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Letter to the Editor
contrast to the findings of Hogenesch et al. (2001), theyEstimating the Human Gene Count
found that the validation rate (by virtue of transcript
detection) for predicted genes was only two-thirds as
high as that for known genes (58% versus 85%). This
A recent letter to Cell (Hogenesch et al., 2001) has raised
result implies that the predicted gene lists contain fewer
doubts about the estimate of the total number of human
genes than would be obtained simply by taking their
protein-coding genes provided by the International Hu-
union. If one assumes a false positive rate of about 1/3
man Genome Sequencing Consortium (Lander et al.,
among gene predictions, the expected gene counts2001) and Celera Genomics (Venter et al., 2001). The
would fall from 42,000 to about 32,000. It is noteworthytwo groups had independently produced lists of “known
that the percentage of known genes validating in eachgenes” and “predicted genes” and had made consistent
experiment is identical, indicating the difference in theestimates of the human gene count of 30,000–40,000
results resides in the manner in which predicted genes(Lander et al., 2001) and 26,000–38,000 (Venter et al.,
were selected rather than an undetected difference in2001), and favored predictions near the lower end of
the array experiments themselves.these ranges. In their letter, Hogenesch and colleagues
The presence of false positives in the predicted genecompared the two lists using permissive criteria and
list should be no surprise. The IHGSC estimated thatmade the important observation that, while there was
roughly 20% of their gene list represented false positivegood concordance with respect to the approximately
gene predictions, based on a careful examination of the11,000 known genes (as determined by RefSeq), there
rate of pseudogenes, known genes, and unvalidatedwas much less overlap with respect to predicted
predictions (Lander et al., 2001). It is important to notegenes.
that the IHGSC’s estimate of close to 30,000 humanIn their letter, Hogenesch and colleagues sought to
genes was not based on the fact that their gene listtest whether the gene predictions (including the non-
contained 29,691 putative entries. Rather, it was arrivedoverlapping ones) contained a significant number of
at by careful correction for both false positive and falsegenuinely expressed transcripts. They did so by using
negative rates; the fact that the final estimate is closegene expression microarrays to measure the frequency
to the initial list size is serendipitous.with which transcripts could be detected for a sample
Another difficulty in the extrapolation of these resultsof known genes and predicted genes. They found that
that can lead to an overestimate of the gene count isthe rates were similar for the two groups (roughly 85%)
the partial nature of many of the gene predictions byand concluded that, “These data support the view that
both groups. For example, Celera Genomics noted that,the novel transcripts predicted by both groups encode
while genes annotated based on identity or homologybona fide differentially expressed mRNAs.”
to known transcripts have an average of 7.8 exons, theirThis result has been interpreted by some (but impor-
de novo predicted transcripts contained only 3.7 exonstantly not by the authors themselves) to indicate that all
(and 20% consisted of only a single exon). Thus, a singlepredicted genes are likely to validate at similar rates to
gene may be represented on one or both of the predictedknown genes. If true, this would lead to a much higher
gene lists by multiple fragments. As these fragments aregene count (see, for example, Wade, 2001), in the range
small (and thus less likely to overlap), even permissiveof 42,000 or more (Figure 1 in Hogenesch et al., 2001).
overlap detection among the lists will not identify all ofIn my view, this interpretation is flawed because the
these as belonging to a single gene.experiment did not involve a representative sample of
Hogenesch and colleagues have taken a key steppredicted genes, but rather a significantly biased sub-
toward compiling a complete list of protein coding genesset. Specifically, the test involved a pre-made gene chip
and it will be critical to continue this work and fill out(from Affymetrix) that contained probes for both known
the many partial predictions in the IHGSC and Celeragenes and gene predictions corresponding to Unigene
lists. However, their results cannot be taken as compel-clusters supported by extensive EST evidence. The pre-
ling evidence that the human gene count is substantiallydicted genes on this chip therefore represent those pre-
higher than previously estimated (Lander et al., 2001;dictions that are most likely to be correct: only a minority
Shoemaker et al., 2001). It is important to point out thatof computational gene predictions come with such
the authors themselves do not draw this conclusion andstrong supporting biological evidence. If extrapolated
this letter aims only to clear up a common misinterpreta-without taking this bias into account, the results of this
tion of their data. If the true gene count is higher thantest will lead to an overestimate of the percentage of
current estimates, it is my view that the excess will likelygene predictions that correspond to true protein-coding
consist of genes which are not well predicted by currentgenes.
techniques (such as those not represented significantlyAn appropriate experiment would require using a de
in EST libraries and showing little homology to knownnovo array containing random samples from the known
genes) and thus are present on neither of the existingand predicted gene lists. In fact, such an experiment
lists. Techniques for interpreting gene prediction usinghas already been done and was reported in an article
homology to the soon complete sequence of the mousealongside the IHGSC report. Shoemaker and colleagues
genome and more sensitive technology for detecting(2001) created an array representing all known and pre-
expressed transcripts should shed considerable lightdicted exons on chromosome 22 and tested for expres-
sion verification under 69 experimental conditions. In on this still outstanding question.
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